← FDA DRUG APPROVALS

FDA ANDA · ANDA062531

GENTAMICIN SULFATE

Sponsor: FOUGERA PHARMS INC

APPLICATION
ANDA062531
TYPE
ANDA
ORIGINAL APPROVAL
1984-07-05
LATEST ACTION
2004-10-29
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

GENTAMICIN SULFATEDiscontinued
GENTAMICIN SULFATE EQ 0.1% BASE · CREAM · TOPICAL

Approval history

2004-10-29Labeling · Supplement 8AP
2002-03-19Manufacturing (CMC) · Supplement 7AP
1996-03-07Manufacturing (CMC) · Supplement 6AP
1993-12-29Labeling · Supplement 5AP
1993-02-02Labeling · Supplement 4AP
1989-04-26Manufacturing (CMC) · Supplement 3AP
1984-07-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →